News | August 23, 2025
Star Health Insurance settles claims of Rs.11,500 Cr
The company has improved access to quality healthcare for seniors across both urban and rural areas
The company has improved access to quality healthcare for seniors across both urban and rural areas
Adds fast-growing and only approved medicine for advanced and indolent systemic mastocytosis to the Sanofi portfolio
New facility will support plans to advance J&J’s portfolio and pipeline of transformational medicines for cancer, immune-mediated and neurological diseases
Novel illumination system with key components molded in Radel® PPSU for durability and repeated sterilization
Expand the scope of the Production-Linked Incentive (PLI) scheme and increase its allocation to cover more pharmaceutical products and raw materials
The robotic surgery program has continually pushed the boundaries of medical technology
The launch of Cefepime-Enmetazobactam marks a significant milestone for India's pharmaceutical industry in fight against AMR
225Ac-PSMA-Trillium is an investigational next-generation PSMA-targeted alpha therapy with potential to treat patients with advanced metastatic prostate cancer
This partnership combines Tata Elxsi's design and technology expertise along with Dräger's expertise in medical and safety technology
ICMR’s budgetary allowance has increased by 4-fold in the past 10 years, showcasing our commitment towards Health Research
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
